Co-Diagnostics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Co-Diagnostics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10538
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Co-Diagnostics Inc (Co-Diagnostics) is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The company’s products include HCV RNA real-time PCR kit, HIV RNA real-time PCR kit, malaria DNA real-time PCR kit, and TB complex DNA kit. Its products finds application in window period detection in blood screening, viral load for monitoring the success of treatment, and infant diagnosis for detecting disease in infants, among others. The company’s technologies comprise Co-Dx, a suite of mathematically-engineered DNA-based polymerase chain reaction diagnostics products, and Adaptivex which helps primers address the challenge of unexpected mutations. Its technology is designed for new generation mobile point-of-care diagnostic devices, and commercially available devices. Co-Diagnostics is headquartered in Sandy, Utah, the US.

Co-Diagnostics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Co-Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Co-Diagnostics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Co-Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Co-Diagnostics Inc, Medical Devices Deals, 2012 to YTD 2018 8
Co-Diagnostics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Co-Diagnostics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Co-Diagnostics Raises USD0.8 Million in Venture Financing 10
Partnerships 11
Co-Diagnostics Forms Joint Venture with Synbiotics 11
Equity Offering 12
Co-Diagnostics Plans to Raise up to USD25 Million in Public Offering of Securities 12
Co-Diagnostics Inc – Key Competitors 13
Co-Diagnostics Inc – Key Employees 14
Co-Diagnostics Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 15
Recent Developments 16
Strategy And Business Planning 16
Nov 07, 2017: Co-Diagnostics Manufacturing Joint Venture Breaks Ground in India 16
Financial Announcements 17
Nov 15, 2017: Co-Diagnostics Reports Q3 Financial Results and Updates Corporate Developments 17
Product News 18
Feb 21, 2018: Co-Diagnostics Ships Product to India for Validation Study 18
Other Significant Developments 19
Mar 22, 2018: Co-Diagnostics Announces Construction Update at JV Manufacturing Facility in India 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Co-Diagnostics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Co-Diagnostics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Co-Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Co-Diagnostics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Co-Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Co-Diagnostics Inc, Medical Devices Deals, 2012 to YTD 2018 8
Co-Diagnostics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Co-Diagnostics Raises USD0.8 Million in Venture Financing 10
Co-Diagnostics Forms Joint Venture with Synbiotics 11
Co-Diagnostics Plans to Raise up to USD25 Million in Public Offering of Securities 12
Co-Diagnostics Inc, Key Competitors 13
Co-Diagnostics Inc, Key Employees 14
Co-Diagnostics Inc, Subsidiaries 15
Co-Diagnostics Inc, Joint Venture 15

List of Figures
Co-Diagnostics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Co-Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Co-Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Co-Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Co-Diagnostics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Co-Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Co-Diagnostics Inc, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[Co-Diagnostics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Orix Corporation:企業の戦略・SWOT・財務分析
    Orix Corporation - Strategy, SWOT and Corporate Finance Report Summary Orix Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Callaway Golf Co (ELY):企業の財務・戦略的SWOT分析
    Callaway Golf Co (ELY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Mithra Pharmaceuticals SA (MITRA):企業の財務・戦略的SWOT分析
    Summary Mithra Pharmaceuticals SA (Mithra) is a developer and manufacturer of over the counter products and prescription drugs for women’s health and other applications. The company offers products such as estelle, donesta, tibelia, zoreline and myring, among others. Its products are used in the tre …
  • Harpoon Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Harpoon Therapeutics Inc (Harpoon Therapeutics) is a biotechnology company that offers solutions for immune-oncology diseases. The company provides products portfolio such as of HPN424, prostate specific antigen and harnesses a technology named TriTAC technology. It employs TriTAC technology …
  • WebMD Health Corp:企業の戦略的SWOT分析
    WebMD Health Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Luby’s Fuddruckers Restaurants, LLC:企業の戦略・SWOT・財務情報
    Luby's Fuddruckers Restaurants, LLC - Strategy, SWOT and Corporate Finance Report Summary Luby's Fuddruckers Restaurants, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Noble Corporation Plc (NE):石油・ガス:M&Aディール及び事業提携情報
    Summary Noble Corporation Plc (Noble) is an offshore drilling contractor for the oil and gas industry. It provides contract drilling services with its fleet of mobile offshore drilling units. The company’s offshore rig fleet operates in the global market and provides contract drilling services. Nobl …
  • Living Cell Technologies Ltd (LCT):医療機器:M&Aディール及び事業提携情報
    Summary Living Cell Technologies Ltd (LCT) is a biotechnology company that develops cell-based therapeutics for the treatment of neurological diseases, diabetes, and stroke and hearing loss. It focuses on discovering regenerative treatments which restore function using naturally occurring cells. LCT …
  • Airgas Inc:企業の戦略的SWOT分析
    Airgas Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Goodwin Biotechnology Inc-製薬・医療分野:企業M&A・提携分析
    Summary Goodwin Biotechnology Inc (GBI), a subsidiary of Wallace Pharmaceuticals Pvt Ltd is a healthcare company that develops and manufactures vaccines, monoclonal antibodies, recombinant proteins and bioconjugates. The company offers cell culture, purification, bioconjugation, biosimilars, aseptic …
  • Astrazeneca Pharma India Ltd (ASTRAZEN):企業の財務・戦略的SWOT分析
    Summary AstraZeneca Pharma India Ltd (AstraZeneca), is a biopharmaceutical company that discovers, develops, and commercializes medicines. The company offers products in the therapeutic areas including cardiovascular and metabolic diseases, respiratory, maternal healthcare, oncology, infection, neur …
  • Epigenomics AG (ECX)-医療機器分野:企業M&A・提携分析
    Summary Epigenomics AG (Epigenomics) is a molecular diagnostics company which develops and commercializes in-vitro diagnostic (IVD) tests for screening, early detection and diagnosis of cancer. Its lead product, Epi proColon is a blood-based test for rapid detection of colorectal cancer; and Epi pro …
  • Yakult Honsha Co., Ltd.:企業の戦略・SWOT・財務分析
    Yakult Honsha Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Yakult Honsha Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Van Oord nv:電力:M&Aディール及び事業提携情報
    Summary Van Oord nv (Van Oord), a subsidiary of MerweOord BV, is a contracting company. It is specialized in dredging, marine engineering and offshore projects including oil, gas, and wind. The company primarily undertakes dredging, offshore oil and gas and offshore wind projects. Its activities inc …
  • Cleveland BioLabs Inc (CBLI)-医療機器分野:企業M&A・提携分析
    Summary Cleveland BioLabs Inc (Cleveland) is a biopharmaceutical company that develops and commercializes drugs to treat cancer, orphan indications and protect healthy tissues from radiation and chemotherapy. The company’s product includes entolimod, a recombinant protein which acts as an agonist of …
  • Meggitt Training Systems, Inc.:企業の戦略・SWOT・財務分析
    Meggitt Training Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Meggitt Training Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Antofagasta Plc:企業の戦略・SWOT・財務情報
    Antofagasta Plc - Strategy, SWOT and Corporate Finance Report Summary Antofagasta Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • DxTerity Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary DxTerity Diagnostics Inc (DxTerity) is a medical device company that offers molecular diagnostic solutions. The company develops genomic tests for disease diagnosis. Its patient clinical research platform and dxcollect fingerstick collection kit are used for population scale genomic studies. …
  • Arena Energy LP:石油・ガス:M&Aディール及び事業提携情報
    Summary Arena Energy Lp (Arena) operates as an oil and gas exploration company. It is engaged in developing and exploring of oil and gas in Gulf of Mexico. It identifies and develops investment opportunities in the Gulf of Mexico Shelf. It is also involved in drilling and off-shore activities. The c …
  • VQ OrthoCare:企業の戦略的SWOT分析
    VQ OrthoCare - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆